163 related articles for article (PubMed ID: 26579790)
1. 577-NM YELLOW LASER PHOTOCOAGULATION FOR COATS DISEASE.
Levinson JD; Hubbard GB
Retina; 2016 Jul; 36(7):1388-94. PubMed ID: 26579790
[TBL] [Abstract][Full Text] [Related]
2. Bevacizumab for Coats' disease with exudative retinal detachment and risk of vitreoretinal traction.
Ramasubramanian A; Shields CL
Br J Ophthalmol; 2012 Mar; 96(3):356-9. PubMed ID: 21653215
[TBL] [Abstract][Full Text] [Related]
3. Treatment of stage 3 Coats' disease by endolaser photocoagulation via a two-port pars plana nonvitrectomy approach.
Cai X; Zhao P; Zhang Q; Jin H
Graefes Arch Clin Exp Ophthalmol; 2015 Jul; 253(7):999-1004. PubMed ID: 25794987
[TBL] [Abstract][Full Text] [Related]
4. The effects of a treatment combination of anti-VEGF injections, laser coagulation and cryotherapy on patients with type 3 Coat's disease.
Li S; Deng G; Liu J; Ma Y; Lu H
BMC Ophthalmol; 2017 May; 17(1):76. PubMed ID: 28532448
[TBL] [Abstract][Full Text] [Related]
5. Classification and management of Coats disease: the 2000 Proctor Lecture.
Shields JA; Shields CL; Honavar SG; Demirci H; Cater J
Am J Ophthalmol; 2001 May; 131(5):572-83. PubMed ID: 11336931
[TBL] [Abstract][Full Text] [Related]
6. Long-Term Outcomes of Total Exudative Retinal Detachments in Stage 3B Coats Disease.
Li AS; Capone A; Trese MT; Sears JE; Kychenthal A; De la Huerta I; Ferrone PJ
Ophthalmology; 2018 Jun; 125(6):887-893. PubMed ID: 29361355
[TBL] [Abstract][Full Text] [Related]
7. Management of idiopathic retinal vasoproliferative tumors by slit-lamp laser or endolaser photocoagulation.
Krivosic V; Massin P; Desjardins L; Le Hoang P; Tadayoni R; Gaudric A
Am J Ophthalmol; 2014 Jul; 158(1):154-161.e1. PubMed ID: 24631475
[TBL] [Abstract][Full Text] [Related]
8. CLINICAL CHARACTERISTICS AND TREATMENT OUTCOMES OF COATS DISEASE IN A SAUDI ARABIAN POPULATION.
Al-Qahtani AA; Almasaud JM; Ghazi NG
Retina; 2015 Oct; 35(10):2091-9. PubMed ID: 25978728
[TBL] [Abstract][Full Text] [Related]
9. TRANSCLERAL DRAINAGE OF SUBRETINAL FLUID, ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR, AND WIDE-FIELD IMAGING-GUIDED LASER IN COATS EXUDATIVE RETINAL DETACHMENT.
Stanga PE; Jaberansari H; Bindra MS; Gil-Martinez M; Biswas S
Retina; 2016 Jan; 36(1):156-62. PubMed ID: 26355946
[TBL] [Abstract][Full Text] [Related]
10. Combination treatment of pediatric coats' disease: a bicenter study in Taiwan.
Lin CJ; Chen SN; Hwang JF; Yang CM
J Pediatr Ophthalmol Strabismus; 2013; 50(6):356-62. PubMed ID: 24669373
[TBL] [Abstract][Full Text] [Related]
11. Intraoperative fluorescein angiography-guided treatment in children with early Coats' disease.
Suzani M; Moore AT
Ophthalmology; 2015 Jun; 122(6):1195-202. PubMed ID: 25824326
[TBL] [Abstract][Full Text] [Related]
12. Coats disease in 351 eyes: Analysis of features and outcomes over 45 years (by decade) at a single center.
Shields CL; Udyaver S; Dalvin LA; Lim LS; Atalay HT; L Khoo CT; Mazloumi M; Shields JA
Indian J Ophthalmol; 2019 Jun; 67(6):772-783. PubMed ID: 31124485
[TBL] [Abstract][Full Text] [Related]
13. Selective photocoagulation in Coats' disease: ten-year follow-up.
Nucci P; Bandello F; Serafino M; Wilson ME
Eur J Ophthalmol; 2002; 12(6):501-5. PubMed ID: 12510719
[TBL] [Abstract][Full Text] [Related]
14. EXTRAMACULAR FIBROSIS IN COATS' DISEASE.
Daruich A; Matet A; Tran HV; Gaillard MC; Munier FL
Retina; 2016 Oct; 36(10):2022-8. PubMed ID: 26991649
[TBL] [Abstract][Full Text] [Related]
15. [Long-term prognosis of 5 cases with stage 3A Coats disease after vitrectomy].
Nakashima H; Emi K; Sato T; Iwahashi-Shima C; Bando H; Ikeda T
Nippon Ganka Gakkai Zasshi; 2012 Jun; 116(6):560-7. PubMed ID: 22774595
[TBL] [Abstract][Full Text] [Related]
16. Coats-like Exudative Vitreoretinopathy in Retinitis Pigmentosa: Ocular Manifestations and Treatment Outcomes.
Moinuddin O; Sathrasala S; Jayasundera KT; Branham KH; Chang EY; Qian CX; Recchia FM; Fahim AT; Besirli CG
Ophthalmol Retina; 2021 Jan; 5(1):86-96. PubMed ID: 32507488
[TBL] [Abstract][Full Text] [Related]
17. Visual outcomes after treatment in pediatric patients with Coats' disease.
Chiu HH; Wan MJ; Kertes PJ; Muni RH; Lam WC
Can J Ophthalmol; 2019 Dec; 54(6):647-652. PubMed ID: 31836093
[TBL] [Abstract][Full Text] [Related]
18. Reemergence of dormant Coats disease after 30 years.
Pérez-Campagne E; Wolfensberger TJ
Eur J Ophthalmol; 2012; 22(3):509-12. PubMed ID: 21928259
[TBL] [Abstract][Full Text] [Related]
19. Coats disease in India: clinical presentation and outcome in 675 patients (690 Eyes).
Dorji P; Raval V; Jalali S; Sahoo N; Padhi TR; Kaliki S; Das AV
Int Ophthalmol; 2023 Feb; 43(2):531-540. PubMed ID: 35987971
[TBL] [Abstract][Full Text] [Related]
20. Risk of Tractional Retinal Detachment Following Intravitreal Bevacizumab Along with Subretinal Fluid Drainage and Cryotherapy for Stage 3B Coats' Disease.
Bhat V; D'Souza P; Shah PK; Narendran V
Middle East Afr J Ophthalmol; 2016; 23(2):208-11. PubMed ID: 27162454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
